| Line Item | 2026-01-23 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $9.02B | +0.6% | +8.7% |
| Cost of Revenue | $3.26B | +6.5% | +17.3% |
| R&D Expense | $722.0M | -4.2% | +7.0% |
| SG&A Expense | $2.96B | -0.3% | +8.8% |
| Operating Income | $1.46B | -13.2% | -11.1% |
| Pre-tax Income | $1.40B | -12.1% | -8.8% |
| Income Tax | $254.0M | +18.1% | +7.2% |
| Net Income | $1.14B | -16.8% | -11.7% |
| EPS (Basic) | $0.89 | -16.8% | -11.9% |
| EPS (Diluted) | $0.89 | -16.8% | -11.9% |
| Line Item | 2026-01-23 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $1.15B | -10.5% | -7.5% |
| Short-term Investments | $7.24B | +2.7% | +8.3% |
| Accounts Receivable | $6.36B | -0.5% | +4.0% |
| Inventory | $6.31B | +2.5% | +12.5% |
| Current Assets | $24.07B | +0.3% | +6.9% |
| Total Assets | $91.48B | +0.2% |
| Line Item | 2026-01-23 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $4.76B | — | — |
| Capital Expenditures | $1.42B | — | — |
| Investing Cash Flow | -$2.02B | — | — |
| Financing Cash Flow | -$3.86B | — | — |
| Free Cash Flow | $3.34B | — | — |
| +1.7% |
| Current Liabilities | $9.49B | -4.4% | -19.8% |
| Long-term Debt | $27.88B | +0.7% | +16.2% |
| Total Liabilities | $42.29B | -0.5% | +4.8% |
| Stockholders' Equity | $48.98B | +0.7% | -0.8% |